Abnormal gamma oscillations, measured by electroencephalography (EEG), have been associated with chronic psychotic disorders, but their prevalence in the early phase of psychosis is less clear. We sought to address this by systematically reviewing the relevant literature. We searched for EEG studies of gamma band oscillations in subjects at high risk for psychosis and in patients with first episode psychosis. The following measures of gamma oscillations were extracted: resting power, evoked power, induced power, connectivity and peak frequency. Forty-five studies with a total of 3099 participants were included. There were potential sources of bias in the study designs and potential artefacts. Although there were few consistent findings, several studies reported decreased evoked or induced power in both high risk subjects and first episode patients. Studies using larger samples with serial EEG measurements, and designs that minimise artefacts that occur at the gamma frequency may advance work in this area.
Introduction
Gamma oscillations, with a frequency of 30-130 Hz, have been proposed as a mechanism linking neural dysfunction to the symptoms of psychosis (McNally and McCarley, 2016) . These oscillations are generated through the synchronised activation of pyramidal neuronal assemblies in the cerebral cortex (Fries et al., 2007) , a process co-ordinated by an inhibition and rebound excitation cycle mediated by the effects of GABAergic, fast spiking interneurons acting on GABA-A receptors (Bartos et al., 2007) . Glutamatergic afferents at NMDA receptors provide excitatory input to these interneurons (Bartos et al., 2007) . Gamma oscillations are well conserved across species (Buzsaki et al., 2013) and are thought to be fundamental for normal corticocortical communication, and cognitive functioning (Fries 2009; Roux et al., 2012) .
There are multiple paradigms that can be used to measure gamma band oscillations. These include the acquisition of data in the resting state, or in the form of evoked (time-locked and phase-locked to a stimulus), or induced (time-locked to a stimulus only) responses (Roach and Mathalon, 2008) . Stimuli can be presented in a variety of different sensory modalities, but are usually visual or auditory. These may be presented as steady state responses (e.g. click trains), oddball stimuli or via a cognitive task. Several features of gamma band oscillations can be measured including their power (amplitude of the waveform, squared), functional connectivity (such as coherence or phase synchrony), and peak frequency within the gamma band. Various factors can potentially modify gamma band oscillations. Linguistic stimuli presented using native versus non-native language, for example, affect the gamma band response (Kösem and van Wassenhove, 2016) , as does the level of the participant's attention to the stimulus (Bauer et al., 2014) . For visual tasks, large high contrast grating stimuli tend to produce gamma responses with highest amplitude (Hermes et al., 2015) . Additionally, multiple pharmacological agents can affect gamma oscillations, including antipsychotics (Alegre et al., 2017) , stimulants (Berke, 2009) , ketamine (Vlisides et al., 2017) , and cannabinoids .
In post mortem studies of schizophrenia, decreased levels of glutamic acid decarboxylase (crucial for GABA synthesis) have been observed in parvalbumin-positive basket cells (Lewis, 2014) , a class of GABAergic interneurons that play a major role in the production of gamma oscillations (Buzsaki and Wang, 2012) . It has been suggested that dysfunction of parvalbumin-positive interneurons, via hypofunction of the NMDA receptor leads to abnormal gamma band oscillations in schizophrenia (Gonzalez-Burgos et al., 2015) , illustrated diagrammatically in Fig. 1 . Dysfunction of this rhythmic activity has thus been suggested as a mechanism for how abnormal neural circuits could lead to the widespread impairments in cognitive function that are seen in patients with schizophrenia (Lesh et al., 2011) . There have been multiple reports of abnormal gamma oscillations in patients with chronic schizophrenia (Rutter et al., 2009; Grutzner et al., 2013; Chen et al., 2014; Hirano et al., 2015) . The extent to which these findings are related to illness chronicity or the effects of long term treatment with antipsychotic medication are unclear. These issues can be addressed by studying gamma band abnormalities in subjects who have recently developed a first episode of psychosis, and have received relatively little treatment.
It is possible that changes in gamma band oscillations reflect pathophysiological changes that are associated with the development of psychosis, and may therefore be evident in subjects who are at high risk for the disorder. The assessment of gamma band oscillations in individuals who are at high risk but have not yet developed a psychotic disorder provides an opportunity to prospectively examine their role in the onset of illness. People who meet criteria for the Clinical High Risk (CHR) state typically present with attenuated psychotic symptoms in the context of a functional decline, and up to 30% of this group will develop a first episode of psychosis within two years (Fusar-Poli et al., 2012) . People with a first degree relative who has a psychotic illness, such as schizophrenia, are also at increased risk of the disorder; with a risk that is 8-10 times greater than that in the general population, but over their entire lifetime, as opposed to the next two years (O'Donovan et al., 2009 ). As they do not have a psychotic disorder but share genetic susceptibility with those who do, subjects at familial high risk may provide endophenotypes, measures of inherited vulnerability (Gottesman and Gould, 2003) . A third group at increased risk of psychosis are people with schizotypy, personality traits that are qualitatively similar to some features of schizophrenia. These traits are thought to reflect an underlying liability for psychosis (Debbane and Barrantes-Vidal, 2015) , though the relationship between schizotypal traits and the risk of subsequently developing psychosis is unclear, with large variations in incidence .
The aim of this review is to critically evaluate the evidence for gamma band abnormalities in the early phase of psychosis. Due to the wide variety in the methods that have been used to measure gamma band oscillations in the literature, we adopted a broad approach: we included all studies quantifying any features of these oscillations in subjects at increased risk for psychosis (CHR, familial risk and schizotypy) or patients with first episode psychosis. We extracted differences in gamma power, frequency and connectivity between these groups and healthy controls.
Methods

Search criteria
We searched the following databases, from inception to January 2017: MEDLINE, EMBASE, PsychINFO. The following combination of search terms was used: EEG AND ((psychosis OR psychotic OR schizophrenia) AND (risk OR prodrom* OR predict OR first episode)) OR schizotypy). Additionally, references of selected studies were manually searched. The search was performed independently by two investigators (TR and ADM). We first examined study titles and abstracts, obtaining full text articles for all studies which were potentially relevant before deciding whether to include.
Selection criteria
We included original research, in English language only, which used human subjects. Studies were included if they reported measures of oscillations within the gamma band (30-130 Hz) using EEG. We included the following populations:
• First episode psychosis, which could include schizophrenia, Fig. 1 . Diagrammatic representation of the production of gamma oscillations. Activation of pyramidal neuronal assemblies, is synchronised by fast-spiking parvalbumin positive GABAergic interneurons. This may be dysfunctional in psychosis through NMDA receptor hypofunction and decreased glutamic acid decarboxylase (GAD). As gamma oscillations are well preserved across species, they can be examined using animal models. They can also be measured directly through EEG.
T.J. Reilly et al. Neuroscience and Biobehavioral Reviews 90 (2018) 381-399 schizoaffective disorder, schizophreniform disorder, psychotic disorder not otherwise specified, bipolar affective disorder with psychotic symptoms or depressive disorder with psychotic symptoms, based on either ICD-10 or DSM criteria. 'First episode' was based on the study author's own definition, which could include, for example, patients undergoing their first hospitalisation for psychosis, or psychotic symptoms presenting for the first time in the past 24 months.
• CHR for psychosis, defined using diagnostic criteria based on a valid clinical tool such as Criteria for Prodromal Syndrome, Basel Screening Instrument for Psychosis, or Structured Interview for Prodromal Syndrome.
• Familial risk, defined as having a first degree relative with a diagnosis of schizophrenia or schizoaffective disorder.
• Schizotypy, defined as populations with measures of schizotypy (such as the Schizotypal Personality Disorder Questionnaire), or those with schizotypal personality disorder based on DSM or ICD-10 criteria.
We excluded reviews, conference abstracts, animal studies, studies using only MEG and studies which measured Event Related Potentials (ERPs) or oscillations outwith the gamma band. We excluded studies of participants with psychotic disorders who were not in their first episode or first hospitalisation. We made no restriction as to what aspect of gamma oscillations were measured and therefore included studies reporting resting, induced and evoked power, functional connectivity and peak gamma frequency. We included overlapping data-sets if they measured different aspects of gamma oscillations.
Data extraction
We recorded the following variables from each article: author, year of publication, study population, task used to produce gamma oscillations and quality of each study. We also extracted all measures of gamma oscillations: resting power, evoked power, induced power, functional connectivity and peak frequency. We recorded whether subjects experiencing their first episode of psychosis were exposed to antipsychotic medication. This was done by two authors (TR and ADM), with disagreement resolved by discussion. Effect sizes in the form of Hedge's g were calculated where possible to correct for bias from small sample sizes.
Assessment of bias
We assessed risk of bias using a modified version of the NewcastleOttawa scale (see Appendix A) for the evaluation of non-randomised studies (Stang, 2010) . The scale evaluates the quality of reporting. According to this tool, every study is judged on three broad categories: the selection of the study groups; the comparability of the groups; and the ascertainment of either the exposure or outcome of interest. We adapted this scale by rating selection of cases as 1 if a validated diagnostic instrument was used and 0 if not. We also rated ascertainment of gamma 1 if this was done blindly in regard to case-control status and 0 if not. In total, a study could score between 0-9, from lowest to highest quality. We also recorded whether the following gamma artefacts had been addressed: power line noise, muscle artefact and saccadic artefact. This was scored from 0-3; we did not score artefact removal which was done by a voltage threshold or manually through visual inspection.
Results
45 studies were included, see PRISMA flow-chart Fig. 2 , comprising a total of 3099 participants. Of these, 42 were independent datasets, as there were 3 pairs of overlapping samples (Kikuchi et al., 2007 (Kikuchi et al., , 2011 Tcheslavski, 2008; Tcheslavski and Beex, 2010 , Ramyead et al., 2015a . 17 studies included first episode patients, 5 were of CHR, 14 of schizotypy and one study (Tada et al., 2014) included both CHR and first episode patients. The measures of gamma oscillations included are described in Table 1 .
First episode psychosis
Studies involving patients with first episode psychosis are shown in Table 2 . These comprised a total of 1125 participants; 522 patients and 603 healthy controls. Most patients had a diagnosis of schizophrenia, defined by DSM-IV criteria in 11 studies (Gallinat et al., 2004; Yeragani et al., 2006; Kikuchi et al., 2007; Flynn et al., 2008; Spencer et al., 2008 , Williams et al., 2009a , 2009b Minzenberg et al., 2010; Kikuchi et al., 2011; Taylor et al., 2013; Tada et al., 2014) , ICD-10 criteria in 3 (Tikka et al., 2014; Garakh et al., 2015; Ramyead et al., 2016) , and a composite of these in 4 (Slewa-Younan et al., 2004; Symond et al., 2005; Andreou et al., 2015b; Leicht et al., 2015) . Five studies were of participants who were naïve to antipsychotic medication (Kikuchi et al., 2007 (Kikuchi et al., , 2011 Ramyead et al., 2016; (Tikka et al., 2014; Yeragani et al., 2006) .
Seven first episode studies utilised resting state paradigms: of these, 4 measured gamma power. Compared with healthy controls, power was increased in one study (Tikka et al., 2014) , but in 3 there were no significant group differences (Yeragani et al., 2006; Andreou et al., 2015b; Garakh et al., 2015) . Increased current source density activity in the left medial frontal gyrus was reported in one study (Ramyead et al., 2016) .
One study (Kikuchi et al., 2007) reported that patients showed increased gamma global field synchronisation. Another described decreased mean coherence of spectral power between C4 and F4 electrodes (Yeragani et al., 2006) , and a trend for reduced mean phase between C4 and F4. Other studies reported increased orthogonalised power envelope correlation (Andreou et al., 2015b) , and increased omega complexity (Kikuchi et al., 2011) , respectively.
Auditory oddball tasks were used in 6 first episode studies. Evoked power was decreased in one (Taylor et al., 2013) . In another, there was no overall difference, although there was a decrease in the right frontal region (Gallinat et al., 2004) . Four studies measured gamma phase synchrony; 3 (Slewa-Younan et al., 2004; Symond, Harris et al., 2005; Williams et al., 2009a) showed a decrease in synchrony, while one (Flynn et al., 2008) showed an increase. The latency of gamma phase synchrony was found to be increased in the study by Slewa-Younan et al. (2004) , but decreased in the study by Symond et al. (2005) . Decreased inter-trial phase locking was reported in the study by Taylor et al. (2013) .
Two first episode studies measured auditory steady state responses. One reported decreased evoked power and phase locking factor in both patients with schizophrenia and patients with affective psychosis (Spencer et al., 2008) . The other reported decreased induced power and inter-trial phase coherence in schizophrenia (Tada et al., 2014) . T.J. Reilly et al. Neuroscience and Biobehavioral Reviews 90 (2018) 381-399 An auditory reaction task demonstrated decreased power and phaselocking factor in first episode schizophrenia . Similarly, induced power was decreased in response to a preparatory cognitive control task, Preparing to Overcome Prepotency (Minzenberg et al., 2010) . Increased phase synchrony in first episode schizophrenia was described in a study of an emotion perception task (Williams et al., 2009b) .
One study examined gamma synchrony in relation to volumetric MRI data in 13 first episode participants (Williams et al., 2009a) , reporting that patients showed an inverse relationship between gamma synchrony and grey matter volume in right temporal and parieto-occipital regions.
Clinical high risk
Studies of CHR subjects are shown in Table 3 . These comprised a total of 370 participants; 229 at risk of psychosis and 141 healthy controls. 3 studies used resting EEG, although 2 of these (Ramyead et al., 2015a (Ramyead et al., , 2015b used the same dataset. The first reported an increase in spontaneous power in the medial prefrontal cortex in CHR patients who later developed psychosis, compared with healthy controls. Machine learning was then applied to this dataset in the second study. Predictions of transition were made using current source density in the gamma and beta bands, with an internally cross-validated area under the receiver operating characteristic curve (AUC) of 0.77. By contrast, Andreou et al. (2015a) found no differences in spontaneous power or resting connectivity in CHR, as quantified by the multivariate interaction measure. Perez et al. (2013) used an auditory reaction task to measure evoked power, total power and phase locking factor. Evoked power was reduced in CHR subjects, whereas total power showed no difference, and there was a trend for phase locking factor to be decreased (p = 0.057). Leicht et al. (2016) used an auditory reaction task to investigate gamma power, peak frequency and phase locking factor. Evoked power and peak frequency were decreased, while there was no difference in latency of peak gamma response between groups. Phase locking factor was decreased, though this did not reach statistical significance (p = 0.092). Tada et al. (2014) used an auditory steady state response paradigm to measure induced power and inter-trial phase coherence, both of which were decreased in the CHR group. Leicht et al. (2016) simultaneously recorded EEG and fMRI while participants performed a cognitively demanding auditory reaction task. Evoked gamma power peaks were coupled with BOLD signal. There was significantly reduced activation of a network which included bilateral auditory cortices, the thalamus anterior cingulate cortex and dorsolateral prefrontal cortex in the CHR group.
Familial high risk
Most of these studies have examined the unaffected relatives of patients with schizophrenia, as shown in Table 4 , apart from Hong et al. (2004) who recruited relatives of patients who also had schizophrenia spectrum personality traits. In total, 1381 participants were included; 640 at familial risk and 741 controls with a negative family history.
Resting EEG was used in 5 studies. Increased spontaneous power was reported by Bandyopadhyaya et al. (2011), and Tikka et al. (2015) , but no difference in power was found by Winterer et al. (2001) , Hong et al. (2012) . Venables et al. (2009) found no group differences with 'eyes closed', but increased spontaneous power in familial high risk subjects with 'eyes open'. In terms of coherence, Bandyopadhyaya et al. (2011) reported decreased spectral coherence at rest, while Tikka et al. (2015) found no differences in inter or intra hemispheric spectral coherence.
Auditory oddball tasks were used in 4 studies. Increased frontal noise power was reported by Winterer et al. (2004) , whereas Diez et al. (2013) found no difference in gamma noise magnitude. Decreased evoked spectral power was reported in unaffected monozygotic twins of schizophrenia patients (Hall et al., 2011a) . Phase locking factor was also decreased but did not reach statistical significance. No differences were reported in total spectral power by Diez et al. (2014) .
Paired auditory clicks were used to examine power, showing decreased evoked power in response to the first stimuli and an increased Total Power Change in power which contains both phase-locked and non-phase-locked power.
Noise Power
Power not time-locked to stimulus, calculated as the difference between the mean power of single trials and the power magnitude in the averaged potential. Also known as noise magnitude.
Peak Frequency
The frequency with the highest magnitude within the gamma range, measured in Hz.
Global Field Synchronisation
Estimates the relative phase synchrony over all electrodes at a given frequency, calculated by the fraction of total power across electrodes that can be explained by a single phase.
Coherence
Consistency of signal between two channels (various measures of consistency may be used, for example spectral power).
Mean Phase Difference Difference in the mean angle of the sinusoidal waveform between two channels.
Orthogonalised Power Envelope Correlation Same-phase signal components are removed (to avoid spurious correlations from the same source) before power estimates and their correlation are calculated.
Omega Complexity
Measure of the global complexity of multi-channel EEG data across the entire scalp, calculated using spatial principal components analysis for all channels.
Inter-Trial Phase Coherence Degree of phase synchronisation across trials between EEG data and time-locking events. Also called inter-trial phase locking and phase-locking factor.
Phase Synchrony A singular estimate of the degree of phase-locking across multiple electrodes. Defined as the inverse of circular variance, which is computed from the phase estimate of each electrode, independent from the amplitude.
Current Source Density A reference-independent measure of the direction, location and intensity of current generators underlying the grossly recorded EEG. Defined as the second spatial derivative of local field potentials.
Multivariate Interaction Measure
Measures the interaction between vector signals based on complex coherence.
T.J. Reilly et al. Neuroscience and Biobehavioral Reviews 90 (2018) 381-399 Table 2 Gamma oscillations in first episode psychosis. T.J. Reilly et al. Neuroscience and Biobehavioral Reviews 90 (2018) 381-399 T.J. Reilly et al. Neuroscience and Biobehavioral Reviews 90 (2018) 381-399 T.J. Reilly et al. Neuroscience and Biobehavioral Reviews 90 (2018) 381-399 Table 5 Gamma Oscillations in Schizotypy. T.J. Reilly et al. Neuroscience and Biobehavioral Reviews 90 (2018) 381-399 response to the second stimuli (Hall et al., 2011b) . However, neither difference was statistically significant. Another paired auditory click paradigm showed no difference in power between groups (Hong et al., 2012) . Auditory state responses were used by Hong et al. (2004) , and Rass et al. (2012) , both showed decreased power in those at familial risk. Decreased phase locking factor was also reported by Rass et al. (2012) . An auditory reaction task showed decreased evoked power and decreased phase locking factor in unaffected siblings of schizophrenia patients (Leicht et al., 2011) .
Schizotypy
Eight studies examined gamma in relation to schizotypy, comprising a total of 223 participants (Table 5 ). Five studies (Vernon et al., 2005; Tcheslavski, 2008; Tcheslavski and Beex, 2010; Koychev et al., 2011b; Fuggetta et al., 2014) divided healthy volunteers into two groups based on their scores on a schizotypy scale, 2 (Skosnik et al., 2006; Kornmayer et al., 2015) correlated measures of gamma with schizotypy scores of healthy volunteers and one (Brenner et al., 2003) compared people with schizotypal personality disorder to healthy controls. The Schizotypy Personality Questionnaire (Raine, 1991) was used to measure schizotypy in 7 studies (Vernon et al., 2005; Skosnik et al., 2006; Tcheslavski, 2008; Tcheslavski and Beex, 2010; Koychev et al., 2011b; Kornmayer et al., 2015) , while Fuggetta et al. (2014) used the Unusual Experiences and Cognitive Disorganisation sub scales of the OxfordLiverpool Inventory of Feelings and Experiences (Mason and Claridge, 2006) .
In the resting state, Fuggetta et al. (2014) reported decreased spontaneous power in subjects with high schizotypy (though this was not statistically significant), while Tcheslavski (2008) reported increased power and Tcheslavski and Beex (2010) reported increased phase synchrony.
There was no difference in evoked power from auditory steady state response in subjects with schizotypal personality disorder compared with healthy controls (Brenner et al., 2003) . Skosnik et al. (2006) described a negative correlation of schizotypal scores with evoked power using auditory steady state responses, while positive correlation of visually evoked power with schizotypy scores was reported by Kornmayer et al. (2015) .
Using a visual working memory task, Koychev et al. (2011b) found that high versus low schizotypy was associated with increased evoked power and decreased phase locking factor in fronto-central and centraloccipital regions. Increased evoked power and decreased phase locking factor was seen in high schizotypy compared with low schizotypy in fronto-central and central-occipital regions. Vernon et al. (2005) used an auditory habituation task to show that individuals with high versus low unreality schizotypy scores had decreased spectral power in the central posterior region, but this was not statistically significant.
Relationship with psychopathology
Thirteen studies examined the relationship between gamma oscillations and psychopathology; 10 in patients with first episode psychosis, 2 in those at CHR and one using both groups. Tikka et al. (2015) reported a negative correlation between low gamma power (30-50 Hz) in the left temporal region and Positive and Negative Syndrome Scale (PANSS) general psychopathology subscale (r = 0.427 p < 0.05); a positive correlation between high gamma power (70-100 Hz) in the right occipital region and the PANSS general psychopathology subscale; and a negative correlation between PANSS total scores and left temporal gamma power at both 30-50 Hz (r = 0.473 p < 0.01) and at 50-70 Hz (r = 0.389 p < 0.05). Taylor et al. (2013) reported positive correlations of phase locking factor and PANSS total scores at Fz (r = 0.47 p = 0.024) and Cz (r = 0.43 p = 0.004). They also reported positive correlation of PANSS total scores and power at Fz (r = 0.71 p < 0.001) and Cz (r = 0.61 p = 0.002). There were trends for positive correlations between power at Fz and PANSS positive subscore (r = 0.39 p = 0.065), PANSS hallucinations subscore (r = 0.39 p = 0.66) and PANSS thought disorder (r = 0.41 p = 0.051). They found no significant correlations between power or phase-locking factor and Scale for the Assessment of Positive Symptoms or Scale for the Assessment of Negative Symptoms. Williams et al. (2009a) reported a negative correlation between change in PANSS reality distortion factor and left temporal synchrony (r = −0.621 p = 0.006), indicating that an improvement in these symptoms was correlated with increased synchrony in this area. Spencer et al. (2008) reported a positive correlation between phase locking and PANSS positive scores (ρ = 0.72 p = 0.003) in patients with first episode schizophrenia but did not find correlations in patients with first episode affective psychosis. Tada et al. (2014) reported negative correlations between PANSS General scores and both inter trial coherence (r = −0.73 p = 0.004), and event related spectral perturbation (r = −0.70 p = 0.008) in patients with first episode schizophrenia. They also reported negative correlation of event related spectral perturbation with both PANSS positive scores (r = −0.53 p = 0.04) and PANSS general psychopathology scores (r = −0.70 p = 0.004) in people at CHR. Garakh et al. (2015) reported negative correlation of PANNS positive score and power at Fp1 (r = −0.368), in patients with a first episode of schizoaffective disorder. Leicht et al. (2015) reported a negative correlation between PANSS negative scores and both phase locking factor (ρ = −0.510 p = 0.05) and evoked power (ρ = −0.600 p = 0.02) in patients with first episode schizophrenia. They also reported a trend for correlation between evoked power and the disorganised factor of PANSS (ρ = 0.504 p = 0.06). Williams et al. (2009b) reported positive correlation of absolute synchrony at left temporal region and PANSS negative scores (R 2 = 0.18) in patients with first episode schizophrenia.
A number of studies found no correlation between symptoms scores and measures of gamma oscillations in patients with first episode psychosis (Gallinat et al., 2004; Flynn et al., 2008; Kikuchi et al., 2011 ) and those at CHR (Perez et al., 2013; Leicht et al., 2016) . Tada et al. (2014) reported that attentional functioning, measured by the Brief Assessment of Cognition in Schizophrenia, was significantly correlated with both inter trial coherence (r = 0.75 p = 0.003) and event related spectral perturbation (r = 0.76 p = 0.003) in patients with first episode schizophrenia. Ramyead et al. (2015a) reported current source density of gamma oscillations was highly correlated with a scale for measuring abstract reasoning (r = 0.734 p < 0.001) in people at CHR who went on to transition to psychosis, but not in those at CHR who did not transition or in healthy controls. Taylor et al. (2013) reported no significant correlations between evoked power or phase locking factor and semantic or working memory measures in patients with first episode schizophrenia. Leicht et al. (2016) report no correlation between error rates or reaction time in a cognitively demanding auditory task and gamma band responses.
Relationship with cognition
Bias
The assessment of bias in each study is reported in Table 5 and the assessment of gamma artefacts in Table 6 .
Discussion
In this systematic review, we identified 45 studies that examined gamma oscillations using EEG in the early phase of psychosis. The large degree of between-study heterogeneity in the participant population studied, in the stimuli used to evoke or induce gamma responses, and in the method employed to quantify the gamma signal precluded a meta-T.J. Reilly et al. Neuroscience and Biobehavioral Reviews 90 (2018) 381-399 analysis. Overall, most studies of CHR subjects, familial risk subjects and first episode patients showed decreased evoked and induced power compared with healthy controls. A number of studies also reported increased resting gamma power in these groups, though this was a less consistent finding.
First episode psychosis
The largest group studied comprised patients with first episode psychosis. Decreased gamma power in response to a task was a relatively consistent finding, with 5 out of 6 studies reported reduced evoked or induced power. The only study which did not find a difference in evoked power overall, reported decreased power in the right frontal region (Gallinat et al., 2004) . This is consistent with the patterns of deficits in gamma band responses found in chronic schizophrenia (Senkowski and Gallinat, 2015) . Mouse models suggest that hypofunction of the NMDA receptor on fast spiking parvalbumin positive interneurons underlies this impairment in gamma rhythm induction (Carlen et al., 2012) .
Spontaneous gamma power was increased in one first episode study, but showed no statistically significant difference in 3 others. This is not in line with the suggestion that schizophrenia is associated with increased resting gamma power (White and Siegel, 2016) . It is also inconsistent with preclinical and computer models of NMDA receptor hypofunction, which predict increased baseline gamma power and decreased power in response to stimulus (Jadi et al., 2016) . These discrepancies relate to spontaneous gamma power being selectively increased during auditory steady state stimulation but not at rest, as has been reported in schizophrenia (Hirano et al., 2015) .
The disconnection hypothesis (Friston et al., 2016) proposes that schizophrenia is associated with decreased markers of connectivity, such as coherence. Several studies reported that phase locking and phase synchrony in response to tasks were decreased, but others reported increases in omega complexity, global field synchronisation, and orthogonalised power envelope correlation. Measures of functional connectivity, such as coherence or phase synchronisation are particularly difficult to compare between studies, as there is no single optimal method. There are at least 42 different methods that can be used to measure oscillatory interactions, which can produce differing results from the same dataset (Wang et al., 2014) . These must be interpreted cautiously, as issues such as common inputs, common references, differences in signal-to-noise ratio between channels and volume conduction can all lead to spurious results (Bastos and Schoffelen, 2015) . Notably, Andreou et al. (2015b) reported increased gamma band connectivity in first episode schizophrenia measured by orthogonalised power envelope correlation but in an overlapping sample, there was no T.J. Reilly et al. Neuroscience and Biobehavioral Reviews 90 (2018) 381-399 difference in connectivity as measured by the multivariate interaction measure (Andreou et al., 2015a) . The findings from studies that used EEG to assess functional connectivity in the early phase of psychosis were thus inconclusive.
High risk subjects
The decrease in both evoked and induced power that was evident in several first episode studies was also found in studies of CHR populations; all 3 studies measuring these features showed reductions compared with healthy controls. There was also a suggestion of increased resting gamma power, though this was a solitary report (Ramyead et al., 2015a) . A measure of neural synchrony in the form of inter-trial phase coherence was decreased in CHR subjects (Tada et al., 2014) , a finding that was also reported in first episode patients.
The familial risk group showed results which were broadly in keeping with those in patients with first episode psychosis. Resting power was either increased or showed no difference between groups, evoked and induced gamma power was reduced in 3 of 4 reports, and phase-locking factor was decreased in all 3 of the studies that reported this measure. As these gamma band abnormalities were present in the unaffected relatives of patients, it suggests they reflect a genetic susceptibility, and thus may represent trait biomarkers of psychosis (Koychev et al., 2011a) .
It was more difficult to interpret the findings from studies of gamma oscillations in people with schizotypy, as they used a variety of different experimental designs, including correlation with schizotypy scores, comparisons between low and high schizotypy individuals, and comparison between schizotypal personality disorders and healthy controls. Furthermore, the results were largely inconsistent across studies.
EEG abnormalities are of particular interest in subjects at CHR for psychosis, as they might be useful in facilitating the prediction of illness onset in a clinical setting. Most studies of CHR subjects to date have involved sample sizes that were too small to permit analysis of the relationship between gamma band measures and later transition to psychosis. Ramyead et al. (2015b) , however, utilised a machine learning approach which incorporated measures of both beta and gamma oscillations from a sample of n = 53 to predict which subjects would go on to develop psychosis. They predicted transition to psychosis with an AUC of 0.77. Perez et al. (2013) did not find differences between CHR subjects who subsequently transitioned and those who did not, in terms of evoked power, total power or phase-locking factor. A key caveat in the interpretation of these findings is that the number of CHR subjects who subsequently developed psychosis in these studies was still small (n = 18 and n = 15, respectively), so they may have lacked the statistical power to detect significant effects.
Correlations between measures of gamma oscillations and psychotic symptomatology were inconsistent between studies, with both positive and negative correlations, as well as no correlation reported. This is similar to the findings in patients with established schizophrenia, where both positive (Spencer et al., 2009; Suazo et al., 2012; Hirano et al., 2015) , negative (Krishnan et al., 2005; Grutzner et al., 2013; Spironelli and Angrilli, 2015) as well as no correlations (Hamm et al., 2012; Roach et al., 2013; Tikka et al., 2014) have been reported. This apparent discrepancy between studies may be partly explained by the use of differing experimental paradigms and differing aspects of gamma oscillations being measured.
Two studies reported significant correlations of gamma oscillations and cognitive scores: using attentional functioning in first episode schizophrenia, and abstract reasoning in those at CHR who went on to develop psychosis. However, another two found no significant correlations. This contrasts with studies which report abnormal gamma oscillations are associated with poor performance in a number of cognitive tasks in patients with established schizophrenia (Senkowski and Gallinat, 2015) . Gamma oscillations are also proposed as a key mechanism for working memory in healthy subjects, particularly when coupled with theta oscillations (Lisman and Jensen, 2013; Roux and Uhlhaas, 2014) . Lack of agreement between studies may be attributable to an inconsistency in the measures of cognitive function and in methods of examining gamma oscillations.
Bias
We assessed each study's risk of bias using an adapted version of the Newcastle-Ottawa scale. However, there are likely more forms of bias which are not detected by this scale. EEG is clearly a versatile investigational technique, whereby multiple measures and analyses can be undertaken in across a range of frequencies. It is conceivable that researchers may carry out multiple tasks and analyses yet only report those which are most favourable. Selective reporting of these outcomes would make a study prone to bias, with more statistically significant outcomes and analyses likely to be included (Ioannidis et al., 2014b) . Unless a study protocol is made available before the study commences, it is difficult to evaluate whether selective reporting has taken place. We did not find evidence for pre-specified outcomes and analyses in any of the included studies. There is suggestion of selective reporting by Donkers et al. (2011) who state in their methods that phase locking factor, evoked power and total power were compared between relatives and controls in the gamma band but do not report the results of these comparisons. Similarly, EEG uses a number of electrodes on which statistical inferences can be made. Some of the included studies used groups of electrodes in their analyses (Tikka et al., 2014) , while others reported results for individual electrodes (Diez et al., 2014) . Not only does this introduce more variability in the reporting of results, it also poses a multiple comparison problem, which no study seemed to account for in their reporting of statistics. The reproducibility of this field could be improved by investigators publishing protocols and analysis plans before conducting research, as well as incentivising replication of previously reported results (Ioannidis et al., 2014a) .
Within the literature examined, there was considerable variability in the way that the definitions of 'first episode' of a psychotic disorder were defined, ranging from presentation with psychotic symptoms for the first time, first hospitalisation for psychosis, or psychotic symptoms presenting for the first time in the past 24 months, or no clear definition at all. Most studies contained participants had been exposed to antipsychotic medication, which have been shown to affect gamma band oscillations (Alegre et al., 2017) .
Multiple artefacts can occur within the gamma band, potentially producing spurious results (Nottage and Horder, 2015) . Power line noise occurs at the frequency of 50 Hz in Europe, which is within the gamma range. It is common to remove a frequency band containing power line noise, for example with a notch filter. However, this could also remove neuronal gamma signal if it occurs at the same frequency and it may produce spurious oscillations in adjacent frequency bands (Nottage and Horder, 2015) . Instead, power line noise should be removed by noise cancellation (Nottage et al., 2013) or negated by using an electrically shielded room. Electrical activity of extra-ocular muscles associated with blinking is conventionally removed using regression weights calculated from average blink potentials, which are below the gamma frequency (Semlitsch et al., 1986) . In contrast, orbicularis oculi contraction during blinks occur within the gamma band and as yet, there are no published methods for removing this artefact (Nottage and Horder, 2015) . Therefore, it can only be reduced by keeping eyes closed or by excluding anterior electrodes from analysis. It has been demonstrated that saccadic eye muscle contraction accounts for previously published induced broad band gamma response 200-300 ms after visual stimulus presentation (Yuval-Greenberg and Deouell, 2009) . This is particularly relevant as people at risk of psychosis have been shown to have increased saccadic eye movements (Gschwandtner et al., 2003; van Tricht et al., 2010) . Saccadic muscle potentials can be removed by recording electrical activity at the corner of each eye and subtracting a weighted average of these potentials from the EEG signal (Nottage, 2010) . A study of muscle paralysis suggests a major component of the gamma signal in published research is actually due to muscle activity of the face, scalp and neck (Whitham et al., 2007) . Prolonged contraction of these muscles may particularly occur at times of stress or emotional arousal (Nottage and Horder, 2015) . In order to address scalp and neck muscle artefact, EMG should be recorded and removed, through mathematical modelling (Nottage et al., 2013 ). An alternative way of addressing EMG contamination is through independent component analysis (Uriguen and Garcia-Zapirain, 2015) , but this method risks rejecting a proportion of genuinely neuronal gamma signal, as well as the artefact (Nottage and Horder, 2015) .
Of the 45 studies included, only 6 adequately addressed our prespecified sources of gamma band artefact (Table 7) . Even amongst these, independent component analysis was used to remove artefact associated with ocular and facial electrical activity. This method is open to criticism (Nottage and Horder, 2015) when correcting for saccades and electromyography. 25 studies did not address any of the potential sources of gamma artefact. A failure to adequately address the multiple non-neuronal artefacts within the gamma range may have resulted in the discrepancy between studies included in this review.
Sample size
The sample sizes in most of the studies were small which may have contributed to the inconsistency between studies. The mean sample size was 29 for first episode patients, 38 for CHR subjects, 46 for those at familial risk and 32 for studies of schizotypy. Sample size is a particular issue in studies which seek to link EEG abnormalities in high risk subjects to the subsequent onset of psychosis. Multi-centre studies provide a means of recruiting larger samples, and a number of these are currently ongoing (Addington et al., 2012) . However, the involvement of multiple centres can also introduce site effects, which must be controlled for in the analysis. Travelling subjects undergoing EEG recordings between sites, as well as standardisation of recruitment, presentation of stimuli, and acquisition of data may reduce this variation.
Further research required
This systematic review suggests that gamma oscillations are altered in first episode psychosis and high risk groups, with most evidence for decreased evoked and induced power. However, there were also many inconsistent findings. Although most studies involved auditory stimuli, it is unclear whether this sensory modality is optimal for detecting gamma band abnormalities; visually stimulated gamma responses have Table 7 Assessment of Gamma Artefact Correction. also been shown to be abnormal in schizophrenia (Tan et al., 2013) . A further caveat is that the literature to date is almost entirely comprised of cross-sectional studies. Longitudinal studies are required to determine whether gamma abnormalities are a trait or state biomarker of psychosis, whether they pre-date illness onset and whether they can be used clinically to predict outcome.
It would be useful to integrate gamma band findings in the early phase of psychosis with findings from other neuroimaging techniques. However, few EEG studies to date have also collected data from other imaging modalities (Williams et al., 2009a; Leicht et al., 2016) . Since gamma oscillations are thought to be dependent on GABAergic interneurons, combining EEG with imaging techniques that can examine GABA function (such as MRS or PET) would be of particular interest. There is evidence from work in healthy volunteers that visually induced gamma oscillations measured by MEG are related to GABA-A receptor density, measured by the PET tracer flumazenil (Kujala et al., 2015) . However, earlier reports that GABA concentration in the visual cortex measured by MRS predicts peak gamma frequency (Muthukumaraswamy et al., 2009) were not subsequently replicated (Cousijn et al., 2014) . The use of EEG in combination with other investigational techniques is of particular interest in the prediction of psychosis in subjects who are at high risk, in whom sequential testing using EEG, MRI and blood biomarkers may substantially improve prognostic accuracy in models in CHR populations (Schmidt et al., 2017) . However, the role of gamma oscillations as a biomarker for outcomes in psychosis needs further clarification before its clinical utility can be realised
Limitations
At present, the literature in this area comprises studies that are heterogeneous with respect to the clinical samples, the tasks used to elicit gamma oscillations, the methods used to quantify features of gamma oscillations, and the steps taken to reduce artefacts. This precluded a meta-analysis of the findings, limiting our study to a systematic review. Although we quantified risk of bias using an established tool, there may still have been reporting biases that were less explicit. The amount of data reported by each study was also variable. We calculated effect sizes when the necessary data were available but this was not possible for studies that did not report means, standard deviations, or relevant test statistics. Some studies reported results for each individual EEG electrode used (for example, Diez et al. (2013) ). Rather than listing each electrode, we chose to report data from the electrodes with the greatest signal, as this was the convention used by most of the other studies that we included.
Conclusion
Although at present the literature is too small and heterogeneous to permit a meta-analysis, a systematic review of EEG studies in people at high risk for psychosis and patients with first episode psychosis indicates that decreased evoked and induced gamma band responses are evident in both groups. There is also some evidence that both groups show increased spontaneous power at rest. These findings suggest that EEG measures in the early phase of psychosis have the potential to be used as biomarkers. Studies using larger samples, serial measurements, and designs that minimise the artefacts that occur at the gamma band frequency may advance work in this area.
Acknowledgement
This study was supported in part by a 2014 NARSAD young investigator award to Dr Paolo Fusar-Poli.
Appendix A. Newcastle -Ottawa quality assessment scale case control studies 1. ) Newcastle -Ottawa quality assessment scale case control studies Note: A study can be awarded a maximum of one star for each numbered item within the Selection and Exposure categories. A maximum of two stars can be given for Comparability. 
